Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Trading Update

14 Nov 2017 15:45

RNS Number : 4915W
IDOX PLC
14 November 2017
 

Idox plc

("Idox", the "Company" or the "Group")

Year End Trading Update

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides an update on trading for its financial year ended 31 October 2017.

 

Overview

Idox continued to deliver on its strategy during the year and has grown both revenues and profits. The Company has been successful in winning several important contracts to further its focus on becoming a leading international supplier of software, services, managed services and content to the wide public sector in the UK and abroad. Due to customer disruption in the wake of June's General Election, sign-off on some contract wins, especially within health and transport have been delayed into the new financial year, resulting in an impact to 2017 profit expectations. Due to this timing impact the board now expects EBITDA for the year of about ÂŁ23m, compared with ÂŁ21.5m in 2016. The Board does expect completion / implementation of the contracts affected in the weeks ahead which means the Company starts 2018 with strong momentum.

In all other respects the business has made good progress in the implementation of its strategy. Public Sector and Digital Divisions have seen further adoption of our new digital solutions and we have continued to see market consolidation on our core back office products, with contracts amounting to ÂŁ3.5m being awarded in the final quarter of the year. In addition, the company has been awarded the contract to deliver electronic counting of elections in Malta with an initial value of ÂŁ2.1m.

 

Acquisitions

The integration of Halarose, the supplier of electoral back office software and services to UK local authorities, which Idox acquired in August is progressing well. Halarose helps create a larger, more effective and focused Idox Elections division which will increase market share through cross-selling initiatives to new and existing customers in the UK and Europe.

6PM, the healthcare solutions business acquired in January, has now been fully integrated and has been awarded contracts for 5 new NHS trusts with an order value in excess of ÂŁ2.8m that we expect to be delivered in the first half of the new financial year.

 

Financial position

Group net debt ended the year at ÂŁ32.7m compared with ÂŁ25.1m as at 31 October 2016 and ÂŁ28.2m as at 30 April 2017. The debt figure reflects acquisitions, including 6PM, and the upfront costs of the delayed contract wins.

 

Outlook

The Board remains confident that the Group is well positioned in its markets and carries excellent momentum into 2018. The Group's focus on helping public sector customers improve efficiency and effectiveness through digital transformation continues to provide considerable growth opportunities. The large proportion of annual revenue from recurring and repeating revenues and a solid order book and pipeline underpins the Group's prospects.

 

Notice of Final Results

The Board intends to report the Group's final results on 20 December 2017.

 

Andrew Riley, Chief Executive of Idox, said:

"Overall Idox has made excellent progress with its strategy of organic and acquisitive growth and our products and services continue to gain traction within our markets.

"The timing of completion of some contracts which has spilled into the new financial year gives us a strong start to 2018, we continue to keep tight control of costs and we are encouraged by the opportunities for the year ahead."

 

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the trading update described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Andrew Riley, Chief Executive Officer.

 

 

Enquiries:

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Non-Executive Chairman

Andrew Riley, Chief Executive

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare

Andrew Leach

Charlie Barker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSSVRBUAAAAA
Date   Source Headline
24th Apr 20184:32 pmRNSHolding(s) in Company
24th Apr 201810:24 amRNSHolding(s) in Company
23rd Apr 20183:40 pmRNSHolding(s) in Company
19th Apr 20183:58 pmRNSResult of AGM and Board Change
19th Apr 20183:54 pmRNSAGM Statement and Trading Update
19th Apr 20187:00 amRNSAGM Statement and Trading Update
27th Mar 20185:17 pmRNSDirector/PDMR Shareholding
27th Mar 201811:02 amRNSPosting of Annual Report and Notice of AGM
22nd Mar 20185:27 pmRNSHolding(s) in Company
19th Mar 201811:22 amRNSHolding(s) in Company
15th Mar 20185:17 pmRNSVesting of LTIP
8th Mar 20184:43 pmRNSHolding(s) in Company
1st Mar 201812:25 pmRNSDirectorate Change
1st Mar 201811:30 amRNSHolding(s) in Company
1st Mar 20187:00 amRNSFinal Results
20th Feb 201812:24 pmRNSHolding(s) in Company
2nd Feb 20184:12 pmRNSHolding(s) in Company
2nd Feb 20188:58 amRNSHolding(s) in Company
31st Jan 20184:52 pmRNSHolding(s) in Company
25th Jan 201812:34 pmRNSDirector/PDMR Shareholding
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
3rd Jan 201810:51 amRNSHolding(s) in Company
27th Dec 20171:48 pmRNSHolding(s) in Company
13th Dec 20177:00 amRNSYear End Update and Board Change
14th Nov 20173:45 pmRNSYear End Trading Update
2nd Nov 20171:31 pmRNSDirector Update
22nd Sep 20172:33 pmRNSExercise of Options and Total Voting Rights
20th Sep 20179:32 amRNSHolding(s) in Company
4th Sep 201710:38 amRNSDirectors' Dealing, Exercise of Options & TVR
1st Sep 20176:16 pmRNSHolding(s) in Company
23rd Aug 20176:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAcquisition
4th Aug 20174:20 pmRNSDirector and PCA Dealing
14th Jul 20173:52 pmRNSDirector/PDMR Shareholding
6th Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20175:23 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Jun 20177:00 amRNSHalf-year Report
18th May 20177:00 amRNSHalf Year Trading Update and Notice of Results
17th May 20174:31 pmRNSHolding(s) in Company
18th Apr 20173:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
7th Apr 20172:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20179:22 amRNSDirector and PCA Dealing
24th Feb 201712:53 pmRNSResult of AGM
24th Feb 20177:00 amRNSAGM Trading Update
15th Feb 20172:55 pmRNSHolding(s) in Company
14th Feb 20171:24 pmRNSExercise of Options and Total Voting Rights
10th Feb 20173:39 pmRNSDirector/PDMR Shareholding
6th Feb 20176:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20179:48 amRNSDirectors' Dealing, Exercise of Options and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.